Login / Signup

Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.

Hong Weng PangAndrea LinaresLeena CoulingJessica SantolloLeonardo AnchetaDerek DanielsRobert C Speth
Published in: Endocrine (2019)
Addition of a high molecular weight molecule to Ang II reduced its AT1 receptor binding affinity, but did not significantly alter stimulation of aldosterone release or water consumption. The BSA-Ang II conjugate caused a greater saline appetite than Ang II suggesting that it may be a more efficacious agonist of this beta-arrestin-mediated response than Ang II. The higher potency calcium signaling response suggests that the G-protein-coupled responses predominate at physiological concentrations of Ang II, while the beta-arrestin response requires pathophysiological or pharmacological concentrations of Ang II to occur.
Keyphrases
  • angiotensin ii
  • angiotensin converting enzyme
  • vascular smooth muscle cells
  • photodynamic therapy
  • drug delivery